← United States · Coverage record
US · SEC FORM 4
Fulgent Genetics, Inc.
FLGT · Nasdaq · CIK 0001674930 · Healthcare · Diagnostics & Research
INSIDER SIGNAL
0 qualifying P purchase groups
in the current 180-day scoring window
25 Form 4 transaction lines observed in the same window
8 sales · 17 option, withholding, award, gift or other lines
WHY NO ACTIVE SIGNAL?
Score anatomy
No score is calculated because there is no qualifying purchase in the active window. Unavailable inputs are not treated as zero or as a bearish signal.
Why is there no score?
- No qualifying open-market purchase supplies cluster, size, role, recency or conviction inputs.
- Sales and other Form 4 activity remain visible as context and do not create a negative score.
Sales and other Form 4 activity are shown separately and do not create a negative buy signal. Absence of buying is not scored as bearish.
Insider activity timeline
Owner lanes show the latest 180 days. Symbol shape identifies the transaction type; sales remain context only.
Showing the six most active owners; 1 additional owner(s) remain in Form 4 evidence.
Purchase breadth, concentration & cluster buying
These modules activate when qualifying purchases enter the 180-day research window.
SIGNAL HISTORY
Scores are archived only when the company qualifies for a published US buy-signal snapshot. Last qualifying purchase: 2025-03-05 · Kim Paul.
Recent Form 4 activity
P is an open-market or private purchase. S is a sale. M, F, A and G usually describe exercises, tax withholding, awards and gifts. These categories remain visually separate.
Market context
Market context has not been captured for this ticker yet. The daily market-context job processes the US universe in rotating batches.
Short interest
Short interest is external context reported to FINRA by broker-dealers. It does not affect the Insider Signal.
- Shares short
- 2,238,210
- Previous report
- 2,318,058
- Avg daily volume
- 311,711
- Days to cover
- 7.2
FINRA settlement date: 2026-09-30 · Captured 2026-10-12 · FINRA equity short interest ↗. A share count, published about a week after each of two settlement dates a month; not a percentage of shares outstanding.
Historical equity purchases
Qualifying code P transactions in the local Form 4 history, including purchases outside the current signal window.
| Transaction date | Reporting owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2025-03-05 | Kim Paul | Purchase (P) | Common Stock | 100,000 | USD 15.96 | USD 1,596,000 | SEC filing ↗ |
Form 4 evidence
87 transaction lines in the latest 365-day window; 492 in local history.
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Xie Jian | Sale (S) | Common Stock | 2,127 | USD 19.66 | USD 41,817 | SEC filing ↗ |
| 2026-09-02 | Gao Hanlin | Sale (S) | Common Stock | 1,673 | USD 19.66 | USD 32,891 | SEC filing ↗ |
| 2026-09-01 | Kim Paul | Tax withholding (F) | Common Stock | 2,087 | USD 19.59 | USD 40,884 | SEC filing ↗ |
Show recent Form 4 evidence (30 grouped rows)
| Date | Owner | Type | Security | Shares | Avg. price | Approx. value | Source |
|---|---|---|---|---|---|---|---|
| 2026-09-02 | Xie Jian | Sale (S) | Common Stock | 2,127 | USD 19.66 | USD 41,817 | SEC filing ↗ |
| 2026-09-02 | Gao Hanlin | Sale (S) | Common Stock | 1,673 | USD 19.66 | USD 32,891 | SEC filing ↗ |
| 2026-09-01 | Kim Paul | Tax withholding (F) | Common Stock | 2,087 | USD 19.59 | USD 40,884 | SEC filing ↗ |
| 2026-09-01 | Hsieh Ming | Tax withholding (F) | Common Stock | 4,392 | USD 19.59 | USD 86,039 | SEC filing ↗ |
| 2026-08-27 | Xie Jian | Sale (S) | Common Stock | 1,193 | USD 19.91 | USD 23,753 | SEC filing ↗ |
| 2026-08-27 | Gao Hanlin | Sale (S) | Common Stock | 939 | USD 19.91 | USD 18,695 | SEC filing ↗ |
| 2026-08-26 | Kim Paul | Tax withholding (F) | Common Stock | 1,168 | USD 19.81 | USD 23,138 | SEC filing ↗ |
| 2026-08-26 | Hsieh Ming | Tax withholding (F) | Common Stock | 2,949 | USD 19.81 | USD 58,420 | SEC filing ↗ |
| 2026-07-26 | Xie Jian | Tax withholding (F) | Common Stock | 4,361 | USD 19.67 | USD 85,781 | SEC filing ↗ |
| 2026-07-26 | Kim Paul | Tax withholding (F) | Common Stock | 2,747 | USD 19.67 | USD 54,033 | SEC filing ↗ |
| 2026-07-26 | Gao Hanlin | Tax withholding (F) | Common Stock | 1,645 | USD 19.67 | USD 32,357 | SEC filing ↗ |
| 2026-06-02 | Xie Jian | Sale (S) | Common Stock | 2,146 | USD 17.89 | USD 38,392 | SEC filing ↗ |
| 2026-06-02 | Gao Hanlin | Sale (S) | Common Stock | 1,688 | USD 17.89 | USD 30,198 | SEC filing ↗ |
| 2026-06-01 | Kim Paul | Tax withholding (F) | Common Stock | 2,087 | USD 18.09 | USD 37,754 | SEC filing ↗ |
| 2026-06-01 | Hsieh Ming | Tax withholding (F) | Common Stock | 4,392 | USD 18.09 | USD 79,451 | SEC filing ↗ |
| 2026-05-27 | Xie Jian | Sale (S) | Common Stock | 1,201 | USD 17.60 | USD 21,138 | SEC filing ↗ |
| 2026-05-27 | Gao Hanlin | Sale (S) | Common Stock | 945 | USD 17.60 | USD 16,632 | SEC filing ↗ |
| 2026-05-26 | Kim Paul | Tax withholding (F) | Common Stock | 1,168 | USD 17.67 | USD 20,639 | SEC filing ↗ |
| 2026-05-26 | Hsieh Ming | Tax withholding (F) | Common Stock | 2,949 | USD 17.67 | USD 52,109 | SEC filing ↗ |
| 2026-05-14 | Nohaile Michael | Award / grant (A) | Common Stock | 5,558 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | GROVES REGINA E | Award / grant (A) | Common Stock | 11,117 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-05-14 | Dong Linda | Award / grant (A) | Common Stock | 11,117 | USD 0.00 | USD 0 | SEC filing ↗ |
| 2026-04-26 | Xie Jian | Tax withholding (F) | Common Stock | 4,361 | USD 16.31 | USD 71,128 | SEC filing ↗ |
| 2026-04-26 | Kim Paul | Tax withholding (F) | Common Stock | 2,747 | USD 16.31 | USD 44,804 | SEC filing ↗ |
| 2026-04-26 | Gao Hanlin | Tax withholding (F) | Common Stock | 1,645 | USD 16.31 | USD 26,830 | SEC filing ↗ |
| 2026-03-01 | Xie Jian | Tax withholding (F) | Common Stock | 9,226 | USD 15.33 | USD 141,435 | SEC filing ↗ |
| 2026-03-01 | Kim Paul | Tax withholding (F) | Common Stock | 9,480 | USD 15.33 | USD 145,328 | SEC filing ↗ |
| 2026-03-01 | Hsieh Ming | Tax withholding (F) | Common Stock | 17,566 | USD 15.33 | USD 269,287 | SEC filing ↗ |
| 2026-03-01 | Gao Hanlin | Tax withholding (F) | Common Stock | 7,428 | USD 15.33 | USD 113,871 | SEC filing ↗ |
| 2026-02-26 | Xie Jian | Tax withholding (F) | Common Stock | 1,140 | USD 24.76 | USD 28,226 | SEC filing ↗ |
Multiple price lines in one filing are grouped and share-weighted. Price and value are blank when a grouped filing line lacks price evidence.
Snapshot & identity
| Snapshot date | 2026-10-18 |
|---|---|
| Ranking version | US-v1.2 |
| Data quality | PASS ELIGIBLE · — |
| Ticker | FLGT |
| CIK | 0001674930 |
| Sector | Healthcare |
| Industry | Diagnostics & Research Yahoo Finance |
| SEC SIC | 8071 Services-Medical Laboratories |
| Exchange | Nasdaq |
Data coverage
| Local Form 4 history | 492 transaction lines from 2020-02-10 to 2026-09-02 1 P purchase lines · 151 S sale lines · 340 other lines |
|---|---|
| SEC company submissions | Open SEC filings ↗ |
Local ledger as of 2026-10-18. Mapping status is an audit field and does not erase SEC filing evidence.